HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Atsushi Naganuma Selected Research

Hepatectomy

8/2022A case of conversion hepatectomy for huge hepatocellular carcinoma with adrenal metastasis and vascular invasion after atezolizumab-bevacizumab treatment.
2/2022A case of conversion hepatectomy for huge ruptured hepatocellular carcinoma after transarterial embolization and lenvatinib therapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Atsushi Naganuma Research Topics

Disease

70Hepatocellular Carcinoma (Hepatoma)
05/2024 - 06/2002
19Neoplasms (Cancer)
12/2023 - 04/2007
13Infections
10/2022 - 04/2002
10Neoplasm Metastasis (Metastasis)
12/2023 - 01/2008
8Chronic Hepatitis C
05/2022 - 04/2002
7Liver Neoplasms (Liver Cancer)
05/2024 - 08/2021
7Hepatitis C
04/2022 - 04/2002
7Liver Cirrhosis (Hepatic Cirrhosis)
04/2022 - 01/2013
7Fibrosis (Cirrhosis)
12/2021 - 03/2017
6Fatigue
06/2023 - 03/2020
6Stomach Neoplasms (Stomach Cancer)
03/2023 - 05/2018
6Autoimmune Hepatitis
01/2020 - 01/2013
5Esophageal and Gastric Varices (Esophageal Varices)
11/2023 - 12/2021
4Thrombosis (Thrombus)
08/2023 - 05/2007
4Inflammation (Inflammations)
05/2023 - 08/2019
4Virus Diseases (Viral Diseases)
01/2023 - 04/2007
4Hypertension (High Blood Pressure)
01/2023 - 01/2022
3Fatty Liver
04/2024 - 07/2021
3Liver Diseases (Liver Disease)
04/2024 - 08/2019
3Hemorrhage
04/2024 - 05/2007
3Proteinuria
01/2023 - 08/2022
3Ascites
05/2022 - 10/2020
2Overweight
03/2024 - 02/2023
2Carcinoma (Carcinomatosis)
11/2023 - 09/2022
2Non-alcoholic Fatty Liver Disease
01/2023 - 10/2021
2Alcoholic Fatty Liver
01/2023 - 07/2021
2Diarrhea
01/2023 - 01/2023
2Hepatitis E
10/2022 - 04/2012
2Pancreatic Neoplasms (Pancreatic Cancer)
10/2022 - 01/2022
2Edema (Dropsy)
05/2022 - 04/2021
2Portal Hypertension
04/2022 - 04/2022
2Hypertriglyceridemia
10/2021 - 07/2021
2Microsatellite Instability
09/2020 - 02/2004
2Massive Hepatic Necrosis
10/2016 - 06/2016
1Abdominal Obesity
04/2024
1Atopic Dermatitis (Atopic Eczema)
04/2024
1Varicose Veins (Varicose Vein)
04/2024
1Adenocarcinoma
12/2023
1Hypophysitis
06/2023
1Muscle Weakness
06/2023
1Hypopituitarism (Sheehan's Syndrome)
06/2023

Drug/Important Bio-Agent (IBA)

44atezolizumabIBA
05/2024 - 01/2021
44Bevacizumab (Avastin)FDA Link
05/2024 - 01/2021
25lenvatinibIBA
04/2024 - 03/2020
18AlbuminsIBA
05/2024 - 03/2020
18BilirubinIBA
05/2024 - 08/2019
11Proteins (Proteins, Gene)FDA Link
06/2023 - 06/2002
10Antiviral Agents (Antivirals)IBA
04/2024 - 04/2002
7alpha-Fetoproteins (alpha-Fetoprotein)IBA
12/2023 - 10/2013
6RNA (Ribonucleic Acid)IBA
05/2023 - 04/2012
6Sorafenib (BAY 43-9006)FDA Link
01/2023 - 08/2017
5Serum AlbuminIBA
10/2023 - 01/2021
5NivolumabIBA
03/2023 - 01/2022
5Biomarkers (Surrogate Marker)IBA
03/2023 - 08/2019
5glecaprevir and pibrentasvirIBA
05/2022 - 01/2018
5InterferonsIBA
09/2018 - 04/2002
4Fetal Proteins (Fetoprotein)IBA
05/2024 - 01/2023
4Tumor Biomarkers (Tumor Markers)IBA
08/2023 - 01/2022
4C-Reactive ProteinIBA
01/2023 - 01/2022
4Ribavirin (Virazole)FDA LinkGeneric
02/2018 - 08/2011
3AntibodiesIBA
10/2022 - 01/2013
3ZincIBA
02/2022 - 11/2006
3SofosbuvirIBA
01/2021 - 02/2018
3Carrier Proteins (Binding Protein)IBA
01/2020 - 12/2018
3P-300IBA
08/2019 - 01/2018
2SteroidsIBA
04/2024 - 12/2018
2Adrenal Cortex Hormones (Corticosteroids)IBA
04/2024 - 10/2013
2pembrolizumabIBA
11/2023 - 09/2020
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
11/2023 - 01/2022
2acarboxyprothrombin (PIVKA)IBA
08/2023 - 01/2022
2Alanine Transaminase (SGPT)IBA
05/2023 - 08/2019
2Uric Acid (Urate)IBA
05/2023 - 02/2018
2Immune Checkpoint InhibitorsIBA
03/2023 - 11/2022
2Therapeutic UsesIBA
02/2023 - 07/2021
2Indicators and Reagents (Reagents)IBA
01/2023 - 04/2002
2Immunoglobulin M (IgM)IBA
10/2022 - 01/2017
2Fluorouracil (Carac)FDA LinkGeneric
01/2022 - 05/2007
2Aspartate Aminotransferases (Aspartate Transaminase)IBA
10/2021 - 09/2018
2(R)-2-(3-((benzoxazol-2-yl-d4 (3- (4- methoxyphenoxy- d7)propyl)amino)methyl)phenoxy) butanoic acidIBA
10/2021 - 07/2021
2Messenger RNA (mRNA)IBA
05/2020 - 10/2016
2glecaprevirIBA
12/2019 - 01/2018
2pibrentasvirIBA
12/2019 - 01/2018
2ChemokinesIBA
08/2019 - 12/2018
2NucleotidesIBA
01/2019 - 10/2016
28- cyclohexyl- N- ((dimethylamino)sulfonyl)- 1,1a,2,12b- tetrahydro- 11- methoxy- 1a- ((3- methyl- 3,8- diazabicyclo(3.2.1)oct- 8- yl)carbonyl)cycloprop(d)indolo(2,1- a)(2)benzazepine- 5- carboxamideIBA
09/2018 - 03/2017
2asunaprevirIBA
09/2018 - 03/2017
2daclatasvirIBA
09/2018 - 03/2017
2Cisplatin (Platino)FDA LinkGeneric
05/2018 - 05/2007
1EnzymesIBA
04/2024
1Anti-Bacterial Agents (Antibiotics)IBA
08/2023
1Proton Pump InhibitorsIBA
08/2023
1GlucocorticoidsIBA
06/2023
1B7-H1 AntigenIBA
06/2023
1Xanthine DehydrogenaseIBA
05/2023

Therapy/Procedure

31Therapeutics
05/2024 - 04/2002
5Drug Therapy (Chemotherapy)
12/2022 - 05/2007
3Immunotherapy
12/2022 - 01/2021
2Catheters
10/2023 - 05/2007
2Hepatectomy
08/2022 - 02/2022
1Heavy Ion Radiotherapy
06/2023